文献速递肾癌与肾肿瘤

常规肾肿瘤活检是否与小肾肿块肾切除后良性组织学比例降低相关?

Is Routine Renal Tumor Biopsy Associated with Lower Rates of Benign Histology following Nephrectomy for Small Renal Masses?
PubMed 文献 · J Urol · 2018-04-11

该多中心回顾性研究纳入2013至2015年间因≤4 cm可疑局限性肾细胞癌行肾部分或根治性切除的516例患者共542个小肾肿块,比较常规倾向肾肿瘤活检的中心与选择性活检中心术后良性肿瘤的比例。结果显示总体良性率为11%,常规活检中心显著低于选择性活检中心(5% vs 16%,p<0.001),多变量分析中选择性活检中心发现良性肿瘤的比值比为4.1(95%CI 1.9-8.3)。结论提示常规肾肿瘤活检可减少良性肿瘤的手术及后续并发症。

要点

  • 常规倾向肾肿瘤活检的中心术后良性组织学比例显著低于选择性活检中心(5% vs 16%)。
  • 选择性活检中心发现良性肿瘤的比值比是常规活检中心的4.1倍(95%CI 1.9-8.3)。
  • 常规肾肿瘤活检可能减少小肾肿块的过度治疗及相关并发症。

核心结论

  • 常规肾肿瘤活检可降低良性肿瘤的手术率及其短期和长期并发症风险。
  • 常规肾肿瘤活检可能是减少小肾肿块过度治疗的有价值工具。

研究设计与样本

  • 多中心回顾性研究,纳入2013至2015年间因≤4 cm可疑局限性肾细胞癌(cT1a和pT1a或pT3a)行肾部分或根治性切除的患者。
  • 共纳入516例患者的542个小肾肿块,比较常规倾向活检中心与选择性活检中心术后良性组织学比例。

主要发现

  • 术后组织学良性肿瘤的总比例为11%。
  • 常规倾向活检中心的良性率显著低于选择性活检中心(5% vs 16%,p<0.001)。
  • 多变量分析中,年龄较大、肿瘤较小及选择性活检中心与术后发现良性肿瘤的更高 odds 显著相关。
  • 与常规活检中心相比,选择性活检中心手术发现良性肿瘤的 odds 高4倍(OR 4.1,95%CI 1.9-8.3)。

临床怎么用

  • 对于≤4 cm可疑局限性肾细胞癌的小肾肿块,常规肾肿瘤活检策略可降低术后良性组织学比例,有助于避免不必要的手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Renal tumor biopsies have been proposed as a management alternative to avoid treatment of benign or low risk small renal masses. However, many urologists are reluctant to recommend renal tumor biopsy because they feel its result frequently will not impact management. Our primary objective was to evaluate if centers that routinely favor renal tumor biopsy have lower rates of benign histology after surgery than centers where a selective renal tumor biopsy approach is used. MATERIALS AND METHODS: This was a retrospective multicenter study of patients who underwent partial or radical nephrectomy for a lesion suspicious for localized renal cell carcinoma which measured 4 cm or less (cT1a and pT1a or pT3a) between 2013 and 2015. A logistic regression model was used to examine whether the odds of obtaining a benign tumor following surgery differed between centers that routinely favor renal tumor biopsy and centers where a selective renal tumor biopsy approach is used. RESULTS: A total of 542 small renal masses in 516 patients were included in study. The rate of histologically benign tumors after surgery was 11%. This rate was significantly lower at centers that routinely favor renal tumor biopsy than at centers where a selective renal tumor biopsy approach is used (5% vs 16%, p <0.001). On multivariable analysis older age, smaller tumors and centers where a selective renal tumor biopsy approach is used were significantly associated with greater odds of finding a histologically benign tumor postoperatively. Compared to centers that routinely favor renal tumor biopsy the odds of finding a benign tumor at surgery was 4 times more likely at centers where a selective renal tumor biopsy approach is used (OR 4.1, 95% CI 1.9-8.3). CONCLUSIONS: Routine renal tumor biopsy reduces surgery for benign tumors and the potential for short-term and long-term morbidity associated with these procedures. This study suggests that routine renal tumor biopsy may be a valuable tool to decrease overtreatment of small renal masses.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Richard PO, Lavallée LT, Pouliot F, et al. Is Routine Renal Tumor Biopsy Associated with Lower Rates of Benign Histology following Nephrectomy for Small Renal Masses? J Urol. 2018. PMID: 29653161. doi:10.1016/j.juro.2018.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。